1Foresi A,Paggiaro P.Inhaled corticosteroids and leukotriene modifiers in the acute treatment of asthma exacerbations.Curr Opin Pulm Med,2003,9:52-56.
2Belvisi MG,Hele DJ.Soft steroids:a new approach to the treatment of inflammatory airways diseases.Pulm Pharmacol Ther,2003,16:321-325.
3Aalbers R,Backer V,Kava TT,et al.Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.Curr Med Res Opin,2004,20:225-240.
4Camargo CA,Smithline HA,Malice MP,et al.A randomized controlled trial of intravenous montelukast in acute asthma.Am J Respir Crit Care Med,2003,167:528-533.
5Scottish Intercollegiate Guidelines Network/The British Thoracic Society.British guideline on the management of asthma.Thorax,2003,58:1-94.
6Berger WE.Levalbuterol:pharmacologic properties and use in the treatment of pediatric and adult asthma.Ann Allergy Asthma Immunol,2003,90:583-591.
7Kips JC,Pauwels RA.Long-acting inhaled beta(2)-agonist therapy in asthma.Am J Respir Crit Care Med,2001,164:923-932.
8Ind PW,Villasante C,Shiner RJ,et al.Safety of formoterol by turbuhaler as reliever medication compared with terbutaline in moderate asthma.Eur Respir J,2002,20:859-866.
9Pauwels RA,Sears MR,Campbell M,et al.Formoterol as relief medication in asthma:a worldwide safety and effectiveness trial.Eur Respir J,2003,22:787-794.
10Rodrigo GJ,Rodrigo C.Triple inhaled drug protocol for the treatment of acute severe asthma.Chest,2003,123:1908-1915.
